Comment on “Serum human epididymis protein 4 is associated with the treatment response of concurrent chemo-radiotherapy and prognosis in patients with locally advanced non-small cell lung cancer” by Lan WG et al.

被引：0
|
作者：
G. Yavas
C. Yavas
S. Akyurek
机构：
[1] Selcuk University,Department of Radiation Oncology
[2] Ankara University,Department of Radiation Oncology
来源：
Clinical and Translational Oncology | 2018年 / 20卷
关键词：
Serum HE4; Human Epididymis Protein 4 (HE4); Concurrent Chemoradiotherapy; Shorter RFS; Smoking Index;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：801 / 802
页数：1
相关论文
共 50 条
  • [21] Nijkamp et al. Relating acute esophagitis to radiotherapy dose using FDG-PET in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer. Radiother Oncol 2013. (7)
    International Journal of Radiation Oncology Biology Physics, 2014, 88 (02):
  • [22] Chemo-radiotherapy for advanced non-small cell lung cancer: concurrent or sequential? It's no longer the question: a systematic review
    Liang, Hui-Ying
    Zhou, Hao
    Li, Xue-Lian
    Yin, Zhi-Hua
    Guan, Peng
    Zhou, Bao-Sen
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (03) : 718 - 728
  • [23] Prognostic Value of Early Tumor Regression during Chemo-Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer
    Lin, Angela
    Bezjak, Andrea
    Lim, Gerald
    Le, Lisa
    Higgins, Jane
    Bissonnette, Jean-Pierre
    Sun, Alexander
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S875 - S876
  • [24] Alteration in tumor immune microenvironment after chemo-radiotherapy for locally advanced non-small cell lung cancer.
    Yoneda, Kazue
    Kuwata, Taiji
    Mori, Masataka
    Kanayama, Masatoshi
    Kuroda, Koji
    Ichiki, Yoshinobu
    Tanaka, Fumihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [25] Platinum derivatives alone, a reasonable option to treat locally advanced non-small cell lung cancer with chemo-radiotherapy
    Sanz Rubiales, Alvaro
    del Valle River, Maria Luisa
    Fiorini Talavera, Aldo Bruno
    Fernandez Gonzalez, Maria
    LUNG CANCER, 2015, 89 (01) : 84 - 85
  • [26] Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy
    Wen, Shu Wen
    Everitt, Sarah J.
    Bedo, Justin
    Chabrot, Marine
    Ball, David L.
    Solomon, Benjamin
    MacManus, Michael
    Hicks, Rodney J.
    Moeller, Andreas
    Leimgruber, Antoine
    PLOS ONE, 2015, 10 (11):
  • [27] Computed tomography to assess pulmonary injury associated with concurrent chemo-radiotherapy for inoperable non-small cell lung cancer
    Aviram, G
    Yu, E
    Tai, P
    Lefcoe, MS
    CANADIAN ASSOCIATION OF RADIOLOGISTS JOURNAL-JOURNAL DE L ASSOCIATION CANADIENNE DES RADIOLOGISTES, 2001, 52 (06): : 385 - 391
  • [28] Serial 4DCT/4DPET imaging to predict and monitor response for locally-advanced non-small cell lung cancer chemo-radiotherapy
    Bissonnette, Jean-Pierre
    Yap, Mei Ling
    Clarke, Katy
    Shessel, Andrea
    Higgins, Jane
    Vines, Douglass
    Atenafu, Eshetu G.
    Becker, Nathan
    Leavens, Claudia
    Bezjak, Andrea
    Jaffray, David A.
    Sun, Alexander
    RADIOTHERAPY AND ONCOLOGY, 2018, 126 (02) : 347 - 354
  • [29] Safety and Effectiveness of Chemo-Radiotherapy with Weekly Nab Paclitaxel plus Carboplatin in Locally Advanced Non-Small Cell Lung Cancer
    Sawa, Toshiyuki
    Hasegawa, Takaaki
    Yoshida, Tsutomu
    Ishiguro, Takashi
    Horiba, Akane
    Futamura, Yohei
    Ohno, Yasushi
    Katoh, Tatsuo
    Hayashi, Shinya
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S447 - S447
  • [30] Is Consolidation Chemotherapy after Concurrent Chemo-Radiotherapy Beneficial for Patients with Locally Advanced Non-Small-Cell Lung Cancer?: A Pooled Analysis of the Literature
    Tsujino, Kazuyuki
    Kurata, Takayasu
    Yamamoto, Satomi
    Kawaguchi, Tomoya
    Kubo, Akihito
    Isa, Shunichi
    Hasegawa, Yoshikazu
    Ou, Sai-Hong Ignatius
    Takada, Minoru
    Ando, Masahiko
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 (09) : 1181 - 1189
12345